Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (100.0%)Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID)
Phase 4
Completed
- Conditions
- GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2014-06-18
- Last Posted Date
- 2018-10-24
- Lead Sponsor
- Cornerstone Health Care, PA
- Target Recruit Count
- 43
- Registration Number
- NCT02167035
- Locations
- 🇺🇸
Cornerstone Health Care, High Point, North Carolina, United States
NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness
Phase 4
Completed
- Conditions
- Multiple Sclerosis, Relapsing-Remitting
- Interventions
- First Posted Date
- 2012-05-04
- Last Posted Date
- 2014-01-29
- Lead Sponsor
- Cornerstone Health Care, PA
- Target Recruit Count
- 37
- Registration Number
- NCT01591551
- Locations
- 🇺🇸
South Shore Neurologic Associates, Patchogue, New York, United States
🇺🇸Cornerstone Neurology, High Point, North Carolina, United States
🇺🇸Providence Brain Institute, Portland, Oregon, United States
News
No news found